Search - tctmd.com

Displaying 1 - 20 of 115

Sort: Relevancy | Date

Presentation TCT 2025

Update on CREST-2, or Update on Best Medical Management of Symptomatic and Asymptomatic Cervical Carotid Stenosis

Presenter: Edip Gurol

October 28, 2025

Presentation TCT 2025

Case Presentation: High Risk Asymptomatic Carotid Stenosis Patient: Paladin, CGuard or “How I usually do it?”

Presenter: Peter A. Soukas

October 28, 2025

Presentation TCT 2025

TCT 458: Invasive versus Conservative Management in Patients with Asymptomatic Ischemia: Insights from the ISCHEMIA Trial

Presenter: Sripal Bangalore

October 27, 2025

Presentation TCT 2025

TCT 838: Natural History and Outcomes of Early Aortic Valve Replacement versus Conservative Management in Patients with Asymptomatic Severe Aortic Stenosis: A Meta-Analysis

Presenter: Justin Huang

October 27, 2025

Presentation TCT 2025

Do We Need Advanced Imaging to Phenotype Asymptomatic AS Patients?

Presenter: Joao L. Cavalcante

October 26, 2025

Presentation TCT 2025

Expanding Role of TAVI to Asymptomatic Severe Aortic Stenosis

Presenter: Philippe Genereux

October 26, 2025

Presentation TCT 2025

Predictors of a Positive Treadmill Stress Test in Patients with Asymptomatic Severe Aortic Stenosis: Insights from the EARLY TAVR Treadmill Registry

Presenter: Philippe Genereux

October 25, 2025

Presentation ESC 2025

AMALFI: Active Monitoring for Atrial Fibrillation: A randomized controlled trial of remote screening for asymptomatic atrial fibrillation

Presenter: Rohan Wijesurendra

August 29, 2025

Presentation NY Valves 2025

Discussion

Presenter: Linda D. Gillam

June 26, 2025

Presentation NY Valves 2025

Durability in TAVR and SAVR: What is the Latest Data? Is SAVR data “Generic”?

Presenter: Suzanne J. Baron

June 26, 2025

Presentation NY Valves 2025

TAVR Across the Age Spectrum

Presenter: Molly Ann Szerlip

June 26, 2025

Presentation NY Valves 2025

AVR in Asymptomatic Severe Aortic Stenosis: The EARLY TAVR Trial and Beyond

Presenter: Brian R. Lindman

June 26, 2025

Presentation NY Valves 2025

Where is the Evidence that Watchful Waiting should be the Preferred Strategy for Aortic Stenosis?

Presenter: Sreekanth Vemulapalli

June 26, 2025

Presentation NY Valves 2025

Guideline Directed Indications and Consequences of Delayed AVR in Patients With Asymptomatic, Severe Aortic Stenosis: Results From the EARLY TAVR Trial

Presenter: Allan Schwartz

June 25, 2025

Presentation NY Valves 2025

Do We Need Advanced Imaging to Phenotype Asymptomatic AS Patients? Lessons From the EVOLVED Trial

Presenter: Marc R. Dweck

June 25, 2025

Presentation TCT 2024

TCT 653: Transcatheter or Surgical Aortic Valve Replacement Versus Clinical Surveillance in Asymptomatic Severe Aortic Stenosis: A Systematic Review and Meta-Analysis

Presenter: Philippe Genereux

October 30, 2024

Presentation TCT 2024

Lessons Learned From Recent Clinical Trials (EARLY TAVR and AVATAR)

Presenter: Allan Schwartz

October 30, 2024

Presentation TCT 2024

Can “At Risk” Disease Phenotypes Prioritize Earlier Treatment (EVOLVED)

Presenter: Mark Dweck

October 30, 2024

Presentation TCT 2024

Controversy in Asymptomatic Patients and What Role Will Be Played By CREST 2 Results

Presenter: Teresa Carman

October 29, 2024

Presentation TCT 2024

Case Presentation: High Risk Asymptomatic Carotid Stenosis Patient

Presenter: Steven Abramowitz

October 29, 2024

Advertisement

Update on CREST-2, or Update on Best Medical Management of Symptomatic and Asymptomatic Cervical Carotid Stenosis

Case Presentation: High Risk Asymptomatic Carotid Stenosis Patient: Paladin, CGuard or “How I usually do it?”

TCT 458: Invasive versus Conservative Management in Patients with Asymptomatic Ischemia: Insights from the ISCHEMIA Trial

TCT 838: Natural History and Outcomes of Early Aortic Valve Replacement versus Conservative Management in Patients with Asymptomatic Severe Aortic Stenosis: A Meta-Analysis

Do We Need Advanced Imaging to Phenotype Asymptomatic AS Patients?

Expanding Role of TAVI to Asymptomatic Severe Aortic Stenosis

Predictors of a Positive Treadmill Stress Test in Patients with Asymptomatic Severe Aortic Stenosis: Insights from the EARLY TAVR Treadmill Registry

AMALFI: Active Monitoring for Atrial Fibrillation: A randomized controlled trial of remote screening for asymptomatic atrial fibrillation

Discussion

Durability in TAVR and SAVR: What is the Latest Data? Is SAVR data “Generic”?

TAVR Across the Age Spectrum

AVR in Asymptomatic Severe Aortic Stenosis: The EARLY TAVR Trial and Beyond

Where is the Evidence that Watchful Waiting should be the Preferred Strategy for Aortic Stenosis?

Guideline Directed Indications and Consequences of Delayed AVR in Patients With Asymptomatic, Severe Aortic Stenosis: Results From the EARLY TAVR Trial

Do We Need Advanced Imaging to Phenotype Asymptomatic AS Patients? Lessons From the EVOLVED Trial

TCT 653: Transcatheter or Surgical Aortic Valve Replacement Versus Clinical Surveillance in Asymptomatic Severe Aortic Stenosis: A Systematic Review and Meta-Analysis

Lessons Learned From Recent Clinical Trials (EARLY TAVR and AVATAR)

Can “At Risk” Disease Phenotypes Prioritize Earlier Treatment (EVOLVED)

Controversy in Asymptomatic Patients and What Role Will Be Played By CREST 2 Results

Case Presentation: High Risk Asymptomatic Carotid Stenosis Patient

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content